Evidence map›Paper›PMID 19151386›Full record

ArticleInvestigative ophthalmology & visual science2009

Functional and molecular characterization of the endothelin system in retinal arterioles.

Travis W Hein, Yi Ren, Zhaoxu Yuan, Wenjuan Xu, Sonal Somvanshi, Taiji Nagaoka, Akitoshi Yoshida, Lih Kuo

Open access · greenAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Exercise limits the production of endothelin in the coronary vasculature.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Travis W HeinDepartment of Ophthalmology, Scott and White Eye Institute, Temple, Texas 76504, USA. thein@tamu.edu
Yi Ren
Zhaoxu Yuan
Wenjuan Xu
Sonal Somvanshi
Taiji Nagaoka
Akitoshi Yoshida
Lih Kuo
Baylor Scott & White Medical Center - Temple · USTexas A&M Health Science Center · USAsahikawa Medical College Hospital · JP

Funding

Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar DysfunctionR01EY018420 · NEI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HEIN, TRAVIS W · 2008 to 2012
$1.9M
NEI NIH HHS R01 EY018420NEI NIH HHS R01EY018420
6 · The paper itself

Abstract

purposeActivation of the endothelin (ET) system has been implicated in the pathogenesis of retinal ischemic disease. Although ET-1, the predominant endogenous isoform of ET, has been shown to cause constriction of retinal vessels, the expression and functional significance of its synthesis and the involved specific ET receptors in retinal arterioles remain unknown. The authors examined the roles of ET(A) and ET(B) receptors and of endothelin-converting enzyme (ECE)-1 in ET-1-induced vasomotor responses of single retinal arterioles.

methodsTo exclude systemic confounding effects, porcine retinal arterioles were isolated for vasoreactivity and molecular studies.

resultsIsolated and pressurized retinal arterioles developed basal tone and constricted in a manner dependent on concentration to ET-1. ET-1 precursor big ET-1 elicited time-dependent vasoconstriction over 20 minutes, which was blocked by the ECE-1 inhibitor phosphoramidon. ET(A) receptor antagonist BQ123 inhibited most (approximately 90%) of vasoconstrictions to ET-1 and big ET-1. ET(B) receptor agonist sarafotoxin also elicited concentration-dependent constriction of retinal arterioles but with significantly less potency than ET-1. ET(B) receptor antagonist BQ788 abolished vasoconstriction to sarafotoxin but only slightly reduced responses to ET-1 and big ET-1. Protein and mRNA expressions of ET(A), ET(B), and ECE-1 were detected in retinal arterioles. Immunohistochemistry revealed ET(A) and ET(B) receptors predominantly in smooth muscle and ECE-1 predominantly in endothelium and smooth muscle.

conclusionsET-1 elicits constriction of retinal arterioles predominantly through the activation of smooth muscle ET(A) receptors. Endogenous production of ET-1 from vascular ECE-1 is sufficient to evoke ET(A) receptor-dependent constriction in retinal arterioles.

Indexed as

AnimalsArteriolesAspartic Acid EndopeptidasesBlotting, WesternDose-Response Relationship, DrugEndothelin-1Endothelin A Receptor AntagonistsEndothelin B Receptor AntagonistsEndothelin-Converting EnzymesEndothelium, VascularFemaleFluorescent Antibody Technique, IndirectGlycopeptidesMaleMetalloendopeptidasesMuscle, Smooth, VascularAspartic Acid Endopeptidasescyclo(Trp-Asp-Pro-Val-Leu)Endothelin-1Endothelin A Receptor AntagonistsEndothelin B Receptor AntagonistsEndothelin-Converting EnzymesGlycopeptidesMetalloendopeptidasesPeptides, CyclicphosphoramidonProtease InhibitorsReceptor, Endothelin AReceptor, Endothelin BRNA, Messengersarafotoxins s6Viper Venoms

Identifiers

PMID19151386
PMCPMC2761152
OpenAlexW2065881108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.